J B CHEMICALS AND PHARMA

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Approval by the shareholders of request for re-classification of status from promoter topublic of certain promoters/promoter group members'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 09, 2021

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Resignation of Mr Vijay Bhatt as Chief Financial Officer of the company w.e.f. August 31, 2021.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Earnings call transcript.'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Analysts/Institutional Investor Meet/Con. Call Updates

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Issue of duplicate share certificates Intimation under regulation 39(3) the Securities & Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Newspaper cutting of extract of consolidated financial results for quarter ended on June 30, 2021

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Investor Presentation

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 12, 2021, titled "Press release".

JB Chemicals & Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended June 30, 2021.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Board meeting held on August 12, 2021.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange that Record date for the purpose of Dividend is 02-Sep-2021.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Grant of 2604252 Options.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Newspaper advertisement in connection with the notice of the annual general meeting of the Company to be held on September 9, 2021 through Video Conferencing (VC)/Other Audio Visual Means (OAVM).

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 09, 2021

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Analysts/Institutional Investor Meet/Con. Call Updates

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Result of Postal Ballot'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Loss of Share Certificates

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Revised contact details of Key Managerial Personnel'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Loss of Share Certificates

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Prior Public Notice for Equity Shareholders of the Company with regard to convening of AGM through Video Conferencing (VC) / Other Audio Visual Means (OAVM)

Disclosure under (i) Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with the Securities and Exchange Board of India circular bearing reference no. CIR/CFD/CMD/4/2015 dated September 9, 2015 (ii) Code of practices and procedure for Discloure of UPSI

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Loss of Share Certificates

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Newspaper advertisement in respect of transfer of equity shares of the Company to Investor Education and Protection Fund (IEPF).

Disclosure of related party transactions under Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Loss of Share Certificates

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Newspaper advertisement for Postal Ballot

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding '(1) Disclosure under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (2) Disclosure under Code of practices and procedure for Disclosure of UPSI'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Issue of Postal Ballot Notice'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper cutting of extract of consolidated financial results for the quarter and year ended on March 31, 2021.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding requests received from certain promoters and promoter group members for re- classification of status as public.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated Jun 14, 2021, titled "Press Release on audited consolidated financial results for the quarter and year ended on March 31, 2021.".

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Investor Presentation

JB Chemicals & Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended March 31, 2021.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange that Board of Directors at its meeting held on Jun 14, 2021, recommended Final Dividend of Rs. 8 (400%) per equity share.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Board meeting held on Jun 14, 2021.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Analysts/Institutional Investor Meet/Con. Call Updates

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure of receipt of requests from the promoters/ promoter group membersseeking re-classification of status as public'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Loss of Share Certificates

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Revised contact details of Key Managerial Personnel'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 06, 2021, titled "Launch of new dedicated division RENOVA to enter Nephrology segment in India".

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Institution of new Employee Stock Option Scheme '.

JB Chemicals & Pharmaceuticals Limited has submitted to the Exchange Annual Disclosure as per SEBI Circular dated November 26, 2018.

Promoter/Member of the Promoter Group of the Company has informed the Exchange regarding disclosure under Regulation 30 and Regulation 31(4) of SEBI SAST Regulations 2011 as on March 31, 2021

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Board meeting held on April 01, 2021.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Analysts/Institutional Investor Meet/Con. Call Updates

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Analysts/Institutional Investor Meet/Con. Call Updates